A Rare Side Effect Of Hydroxycholoroqine: Acute Generalised Exanthematous Pustulosıs

Nazife Sule Yaşar Bilge, Tuba Erdoğan


Abstract: Hydroxycholoroqine (HCQ) is a widely used drug in treatment of various rheumatic disease. Even, it is commonly used in treatment of cuteneus manifestations of lupus sometimes the drug it self can cause cutaneus adverse effects. Acute generalised exanthematous pustulosis (AGEP) is a rare kind of dermatosis and herein we report a case who developed AGEP after HCQ usage for treatment of rheumatoid arthritis.

Key words: acute generalized exanthematous pustulosis, adverse effect, hydroxycholoroqine, dermatosis

DOI: http://dx.doi.org/10.20515/otd.09656